Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CARBINOXAMINE MALEATE

CARBINOXAMINE MALEATE

Standard Dose
4MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview CARBINOXAMINE MALEATE is listed in Drugs@FDA under application 090756 (ANDA).

Marketing status: Prescription Active ingredient CARBINOXAMINE MALEATE Form and strength TABLET;ORAL - 4MG Sponsor MISSION PHARMACAL Submission history Latest submission status date: 2011-05-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview CARBINOXAMINE MALEATE is listed in Drugs@FDA under application 090756 (ANDA). Marketing status: Prescription Active ingredient CARBINOXAMINE MALEATE Form and strength TABLET;ORAL - 4MG Sponsor MISSION PHARMACAL Submission history Latest submission status date: 2011-05-27 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.